Altrinsic Global Advisors’s BioNTech BNTX Stock Holding History

Altrinsic Global Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-496,771	Closed	-$52.9M	–	47
2025 Q2	$52.9M	Sell	496,771 -123,995	-20%	-$12.5M	1.92%	14
2025 Q1	$56.5M	Sell	620,766 -6,727	-1%	-$753K	2.79%	12
2024 Q4	$71.5M	Sell	627,493 -25,213	-4%	-$2.88M	3.46%	11
2024 Q3	$77.5M	Sell	652,706 -23,513	-3%	-$2.16M	3.3%	13
2024 Q2	$54.3M	Sell	676,219 -36,489	-5%	-$3.34M	2.42%	14
2024 Q1	$65.7M	Sell	712,708 -41,680	-6%	-$4M	2.97%	12
2023 Q4	$79.6M	Buy	754,388 +53,967	+8%	+$5.44M	3.38%	11
2023 Q3	$76.1M	Sell	700,421 -7,972	-1%	-$882K	2.94%	12
2023 Q2	$76.5M	Buy	708,393 +159,498	+29%	+$17.9M	2.93%	11
2023 Q1	$68.4M	Buy	+548,895	New	+$75.4M	2.65%	11

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Altrinsic Global Advisors's BNTX Position: Q3 2025 in Review

Altrinsic Global Advisors sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 496,771 shares — an estimated $52.9M sold.

Altrinsic Global Advisors first reported a position in BNTX in Q1 2023 and held it in 10 quarters. The position peaked at $79.6M in Q4 2023. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

Altrinsic Global Advisors reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
Altrinsic Global Advisors sold 496,771 BioNTech shares in Q3 2025, an estimated $52.9M.
Altrinsic Global Advisors first reported a position in BioNTech in Q1 2023 and held it in 10 quarters.
Altrinsic Global Advisors's BioNTech position peaked at $79.6M in Q4 2023.
254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Altrinsic Global Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.